A molecular approach to breast imaging

Journal of Nuclear Medicine

Volumn 55, Issue 2, 2014, Pages 177-180

  Fowler, Amy M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Breast; Breast cancer; Breast specificg imaging; Molecular imaging; Oncology; PET; PET CT; Positron emission mammography; Positron emission tomography; Radiopharmaceuticals

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BREAST CANCER; BREAST SPECIFIC GAMMA IMAGING; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG RESPONSE; HUMAN; IMAGING AND DISPLAY; META ANALYSIS (TOPIC); MOLECULAR DIAGNOSIS; MOLECULAR IMAGING; NON INVASIVE PROCEDURE; POSITRON EMISSION MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING; BREAST; BREAST TUMOR; BREAST-SPECIFIC Γ IMAGING; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GAMMA CAMERA; MAMMOGRAPHY; METHODOLOGY; MULTIMODAL IMAGING; ONCOLOGY; PET; PET/CT; POSITRON-EMISSION MAMMOGRAPHY; REPRODUCIBILITY; REVIEW;

BREAST; BREAST CANCER; BREAST-SPECIFIC Γ IMAGING; MOLECULAR IMAGING; ONCOLOGY; PET; PET/CT; POSITRON-EMISSION MAMMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; FEMALE; GAMMA CAMERAS; HUMANS; MAMMOGRAPHY; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84897929970     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.113.126102     Document Type: Article

References (26)

1. Hruska CB, O'Connor MK. Nuclear imaging of the breast: translating achievements in instrumentation into clinical use. Med Phys. 2013;40: 050901.
2. Xu HB, Li L, Xu Q. Tc-99m sestamibi scintimammography for the diagnosis of breast cancer: meta-Analysis and meta-regression. Nucl Med Commun. 2011;32: 980-988.
3. Bruening W, Uhl S, Fontanarosa J, Reston J, Treadwell J, Schoelles K. Noninvasive Diagnostic Tests for Breast Abnormalities: Update of a 2006 Review. Comparative effectiveness review no. 47. AHRQ publication 12-EHC014-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012: 27-34.
4. 18F-FDG PET in oncology. J Nucl Med. 2008;49: 480-508.
5. Kalinyak JE, Berg WA, Schilling K, Madsen KS, Narayanan D, Tartar M. Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT. Eur J Nucl Med Mol Imaging. October 2, 2013 [Epub ahead of print].
6. Eo JS, Chun IK, Paeng JC, et al. Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. Breast. 2012;21: 66-71.
7. Surti S. Radionuclide methods and instrumentation for breast cancer detection and diagnosis. Semin Nucl Med. 2013;43: 271-280.
8. Sun Y, Wei W, Yang HW, Liu JL. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-Analysis. Eur J Nucl Med Mol Imaging. 2013;40: 450-463.
9. MacDonald L, Edwards J, Lewellen T, Haseley D, Rogers J, Kinahan P. Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II. J Nucl Med. 2009;50: 1666-1675.
10. Moliner L, Gonzalez AJ, Soriano A, et al. Design and evaluation of the MAMMI dedicated breast PET. Med Phys. 2012;39: 5393-5404.
11. Schilling K, Narayanan D, Kalinyak JE, et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2011;38: 23-36.
12. Plana MN, Carreira C, Muriel A, et al. Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-Analysis. Eur Radiol. 2012;22: 26-38.
13. Brem RF, Shahan C, Rapleyea JA, et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol. 2010;17: 735-743.
14. Killelea BK, Gillego A, Kirstein LJ, et al. George Peters Award: how does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? Am J Surg. 2009;198: 470-474.
15. Zhou M, Johnson N, Gruner S, et al. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg. 2009;197: 159-163.
16. Kim BS. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI. Ann Nucl Med. 2012;26: 131-137.
17. Berg WA, Madsen KS, Schilling K, et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology. 2011;258: 59-72.
18. Hylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy -results from ACRIN 6657/I-SPY TRIAL. Radiology. 2012;263: 663-672.
19. Yuan Y, Chen XS, Liu SY, Shen KW. Accuracy of MRI in prediction of pathologic complete remission in breast cancer after preoperative therapy: a metaanalysis. AJR. 2010;195: 260-268.
20. Mghanga FP, Lan X, Bakari KH, Li C, Zhang Y. Fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography in monitoring the response of breast cancer to neoadjuvant chemotherapy: a meta-Analysis. Clin Breast Cancer. 2013;13: 271-279.
21. Wahner-Roedler DL, Boughey JC, Hruska CB, et al. The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study. Clin Nucl Med. 2012;37: 344-350.
22. Rhodes DJ, Hruska CB, Phillips SW, Whaley DH, O'Connor MK. Dedicated dualhead gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011;258: 106-118.
23. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. 2013;10: 11-14.
24. Conners AL, Maxwell RW, Tortorelli CL, et al. Gamma camera breast imaging lexicon. AJR. 2012;199: W767-W774.
25. Narayanan D, Madsen KS, Kalinyak JE, Berg WA. Interpretation of positron emission mammography: feature analysis and rates of malignancy. AJR. 2011; 196: 956-970.
26. BI-RADS Breast Imaging and Reporting Data System: Breast Imaging Atlas. 4th ed. Reston, VA: American College of Radiology; 2003.